Sign In
test

Andrew Weinstein

Affinity Asset Advisors, Llc

Assets Managed
$1.936B
Holdings
103
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
10.34%(2Q avg: 31.61%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Affinity Asset Advisors, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 103 positions.

Assets under management

The assets under management (AUM) of Affinity Asset Advisors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.936B in assets, with a quarterly growth rate of 10.34% and a 2-quarter average growth rate of 31.61%. The portfolio is managed by Andrew Weinstein, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
SPY
Spdr S&p 500 Etf Trust
Recent Activity
New Position
6.72%
$130.068M↓ Put
200,000 shares@ $650.34 avg price
APGE
Apogee Therapeutics Inc
Recent Activity
Increased 4.05%
5.59%
$108.152M
1.285M shares@ $84.17 avg price
XENE
Xenon Pharmaceuticals Inc
Recent Activity
Increased 34%
5.04%
$97.401M
1.675M shares@ $58.15 avg price
ERAS
Erasca Inc
Recent Activity
Increased 37.18%
4.48%
$86.563M
5.35M shares@ $16.18 avg price
INSM
Insmed Inc
Recent Activity
Increased 6.67%
4.06%
$78.49M
480,000 shares@ $163.52 avg price
ROIV
Roivant Sciences Ltd
Recent Activity
Increased 64.71%
4.01%
$77.56M
2.8M shares@ $27.7 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
Decreased -10.71%
3.34%
$64.52M
1.279M shares@ $50.45 avg price
CNTA
Centessa Pharmaceuticals-adr
Recent Activity
Increased 133.12%
2.88%
$55.608M
1.4M shares@ $39.72 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
Decreased -8.1%
2.83%
$54.772M
170,000 shares@ $322.19 avg price
ANAB
Anaptysbio Inc
Recent Activity
Increased 111.39%
2.7%
$52.132M
940,000 shares@ $55.46 avg price

1-10 of 103